Sterna Biologicals names new chief executive officer
8 February 2018 -

Sterna Biologicals, a Clinical stage immunotherapy company, has named Christian Pangratz as its new chief executive officer, it was reported yesterday.

Pangratz was previously working with Vectura Group as senior vice president of business development. He has more than 25 years of life science experience with expertise in the areas of strategic planning, corporate and business development, alliance and project management, new product planning, marketing and sales. He has also held roles for Nektar Therapeutics, Bayer and Pfizer.

Jonas Renz, managing director of Sterna, said, 'Christian is a proven senior executive with extensive leadership experience and an impressive track record. He was instrumental in a number of successful business transformations and high-value transactions across various therapeutic areas that are highly relevant to Sterna.'